Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug target gene-based analyses of drug repositionability in rare and intractable diseases.

Scientific reports - 11 Jun 2021

Sakate Ryuichi, Kimura Tomonori

Abstract excerpt

Drug development for rare and intractable diseases has been challenging for decades due to the low prevalence and insufficient information on these diseases. Drug repositioning is increasingly being used as a promising option in drug development. We aimed to analyze the trend of drug repositioning and inter-disease drug repositionability among rare and intractable diseases. We created a list of rare and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Computational Biology
Share to Drug Repositioning

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance

Share to Genotype

Share to Molecular Targeted Therapy

Share to Rare Diseases

Source

Open in PubMed Open full text

Identifiers

PMID: 34117295
DOI: 10.1038/s41598-021-91428-4
PMCID: PMC8196006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug target gene-based analyses of drug repositionability in rare and intractable diseases.PMID 34117295Read ↗

Target-Based Drug Repositioning Using Large-Scale Chemical-Protein Interactome Data.Semantic proximity Read ↗

Systematic drug repositioning for a wide range of diseases with integrative analyses of phenotypic and molecular data.Semantic proximity Read ↗

Mining drug-disease relationships as a complement to medical genetics-based drug repositioning: Where a recommendation system meets genome-wide association studies.Semantic proximity Read ↗

A miRNA-driven inference model to construct potential drug-disease associations for drug repositioning.Semantic proximity Read ↗

Computational drug repositioning through heterogeneous network clustering.Semantic proximity Read ↗

Drug repositioning using disease associated biological processes and network analysis of drug targets.Semantic proximity Read ↗

Computational Drug Repositioning with Random Walk on a Heterogeneous Network.Semantic proximity Read ↗

Drug repositioning for dengue haemorrhagic fever by integrating multiple omics analysesSemantic proximity Read ↗

Extracting and characterizing gene-drug relationships from the literature.Semantic proximity Read ↗

Literature-based prediction of novel drug indications considering relationships between entities.Semantic proximity Read ↗

A survey of current trends in computational drug repositioning.Semantic proximity Read ↗

Trend of clinical trials of new drugs for rare diseases in China in recent 10 yearsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.